H. Gerhartz

1.1k total citations
42 papers, 357 citations indexed

About

H. Gerhartz is a scholar working on Hematology, Oncology and Genetics. According to data from OpenAlex, H. Gerhartz has authored 42 papers receiving a total of 357 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Hematology, 11 papers in Oncology and 10 papers in Genetics. Recurrent topics in H. Gerhartz's work include Acute Myeloid Leukemia Research (8 papers), Hematopoietic Stem Cell Transplantation (8 papers) and Acute Lymphoblastic Leukemia research (6 papers). H. Gerhartz is often cited by papers focused on Acute Myeloid Leukemia Research (8 papers), Hematopoietic Stem Cell Transplantation (8 papers) and Acute Lymphoblastic Leukemia research (6 papers). H. Gerhartz collaborates with scholars based in Germany, United Kingdom and United States. H. Gerhartz's co-authors include W. Wilmanns, Eckhard Thiel, D. Huhn, Helga Schmetzer, M. Engelhard, Markus Tiemann, Ü. Aydemir, P. Meusers, Henrik Griesser and K. Lennert and has published in prestigious journals such as Blood, International Journal of Cancer and Experimental Cell Research.

In The Last Decade

H. Gerhartz

39 papers receiving 312 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H. Gerhartz Germany 10 120 114 90 81 76 42 357
G. P. Clein United Kingdom 10 73 0.6× 99 0.9× 113 1.3× 78 1.0× 120 1.6× 12 393
F. M. Fink Austria 11 68 0.6× 70 0.6× 190 2.1× 125 1.5× 60 0.8× 21 439
Etsuko Shima Japan 7 99 0.8× 55 0.5× 121 1.3× 143 1.8× 70 0.9× 13 401
LC Bowman United States 6 153 1.3× 45 0.4× 156 1.7× 128 1.6× 43 0.6× 7 424
D. K. Hossfeld Germany 10 49 0.4× 66 0.6× 199 2.2× 105 1.3× 129 1.7× 22 408
CH Weaver United States 14 250 2.1× 86 0.8× 248 2.8× 39 0.5× 54 0.7× 16 411
R. Erttmann Germany 9 112 0.9× 46 0.4× 190 2.1× 42 0.5× 32 0.4× 16 344
Lanier H. Ayscue United States 10 97 0.8× 49 0.4× 107 1.2× 148 1.8× 87 1.1× 11 396
F Teillet France 8 76 0.6× 124 1.1× 140 1.6× 161 2.0× 62 0.8× 30 367
Wolfgang Peter Germany 10 114 0.9× 85 0.7× 63 0.7× 121 1.5× 49 0.6× 17 350

Countries citing papers authored by H. Gerhartz

Since Specialization
Citations

This map shows the geographic impact of H. Gerhartz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Gerhartz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Gerhartz more than expected).

Fields of papers citing papers by H. Gerhartz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Gerhartz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Gerhartz. The network helps show where H. Gerhartz may publish in the future.

Co-authorship network of co-authors of H. Gerhartz

This figure shows the co-authorship network connecting the top 25 collaborators of H. Gerhartz. A scholar is included among the top collaborators of H. Gerhartz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Gerhartz. H. Gerhartz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gerhartz, H., et al.. (2015). Combined Chemotherapy of Acute Myeloblastic Leukemia. Proceedings of the International Symposium on Comparative Leukemia Research. 39. 1142–1146.
2.
Engelhard, M., Günter Brittinger, D. Huhn, et al.. (1997). Subclassification of diffuse large B-cell lymphomas according to the Kiel classification: distinction of centroblastic and immunoblastic lymphomas is a significant prognostic risk factor.. PubMed. 89(7). 2291–7. 90 indexed citations
3.
Schmetzer, Helga, W. Wilmanns, & H. Gerhartz. (1996). Detection of Acute Myeloid Leukemic Cells in Complete Remission and in Extramedullary Sites by Clonal Analyses. Acta Haematologica. 96(2). 83–87. 9 indexed citations
4.
Gerhartz, H., H. Zwierzina, Pierre Fenaux, et al.. (1996). Interleukin-3 plus Low-Dose Cytosine Arabinoside for Advanced Myelodysplasia: A Pilot Study. Cancer Investigation. 14(4). 299–306. 7 indexed citations
5.
Gerhartz, H., et al.. (1993). Chemotherapy Dose and Survival in Advanced Hodgkin’s Disease. Acta Haematologica. 89(3). 137–140. 3 indexed citations
6.
7.
Hiller, Erhard, H. Gerhartz, Markus Löffler, et al.. (1991). Ergebnisse und therapeutische Konsequenzen der Staging Laparotomie beim Morbus Hodgkin. Oncology Research and Treatment. 14(2). 171–177. 4 indexed citations
8.
Delmer, Alain, Marina Karmochkine, M Cadiou, H. Gerhartz, & R Zittoun. (1990). Recurrent spleen enlargement during cyclic granulocyte‐macrophage colony‐stimulating factor therapy for myelodysplastic syndrome. American Journal of Hematology. 34(1). 73–74. 13 indexed citations
9.
Mezger, J., W. Permanetter, H. Gerhartz, et al.. (1990). Philadelphia chromosome-negative acute hematopoietic malignancy: Ultrastructural, cytochemical and immunocytochemical evidence of mast cell and basophil differentiation. Leukemia Research. 14(2). 169–175. 12 indexed citations
10.
Mezger, J., W. Permanetter, H. Gerhartz, et al.. (1990). Philadelphia chromosome‐negative acute hematopoietic malignancy: ultrastructural, cytochemical and immunocytochemical evidence of mast cell and basophil differentiation. European Journal Of Haematology. 44(1). 74–77. 1 indexed citations
11.
Gerhartz, H., et al.. (1988). Epstein‐barr virus‐positive recipient type B‐cells survive in a “complete chimera” after allogeneic bone‐marrow transplantation. International Journal of Cancer. 42(5). 672–676. 3 indexed citations
12.
Gerhartz, H., Eckhard Thiel, Erhard Hiller, et al.. (1988). CHOP and COPBLAM chemotherapy for diffuse large cell non‐Hodgkin's lymphomas: A retrospective comparison. Hematological Oncology. 6(1). 13–19. 5 indexed citations
13.
Iglesias-Rozas, José R., et al.. (1983). Hemorrhagic Infarction of the Basal Ganglia. Oncology. 40(6). 387–391. 5 indexed citations
14.
Dennig, Dieter, et al.. (1983). Dipeptidylaminopeptidase IV (DAP IV) Activity in Normal and Malignant T‐Cell Subsets as Defined by Monoclonal Antibodies. Scandinavian Journal of Haematology. 31(3). 197–205. 16 indexed citations
15.
Gerhartz, H., E Liss, & Helmut Schmidt. (1979). Cyclophosphamide-resistant Yoshida ascites tumor cells and their cross resistance to some alkylating agents. Journal of Cancer Research and Clinical Oncology. 94(3). 257–263. 2 indexed citations
16.
Gerhartz, H., et al.. (1967). Zur Lebenserwartung unbehandelter und behandelter Plasmozytomkranker. Annals of Hematology. 14(4). 217–233. 1 indexed citations
17.
Gerhartz, H., et al.. (1966). Zur hämorrhagischen Cystitis unter der Chemotherapie mit N-Lost-Phosphamidestern. Journal of Molecular Medicine. 44(8). 450–457. 7 indexed citations
18.
Gerhartz, H., et al.. (1964). Zur Morphologie blockierter Mitosen der Hämopoese nach Vincaleukoblastin. Annals of Hematology. 10(1). 26–31. 3 indexed citations
19.
Gerhartz, H.. (1959). Vergleichende Testung von Cytostatica am peripheren Blut und Knochenmark der Ratte. Annals of Hematology. 5(6-7). 360–366. 9 indexed citations
20.
Gerhartz, H.. (1957). [Influence of cancer chemotherapy on hemopoiesis].. PubMed. 15(Sonderbd. 37). 285–90. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by G. P. Clein Breakdown of academic impact, for papers by F. M. Fink Breakdown of academic impact, for papers by Etsuko Shima Breakdown of academic impact, for papers by LC Bowman Breakdown of academic impact, for papers by D. K. Hossfeld Breakdown of academic impact, for papers by CH Weaver Breakdown of academic impact, for papers by R. Erttmann Breakdown of academic impact, for papers by Lanier H. Ayscue Breakdown of academic impact, for papers by F Teillet Breakdown of academic impact, for papers by Wolfgang Peter
Rankless by CCL
2026